Pasadena, CA, United States of America

Kendra Nicole Avery

This inventor holds 8 USPTO granted patents and 1 published patent application, plus 3 CIPO patents and 2 EPO patents. Top assignees: Beckman Research Institute, City of Hope, Thomas Jefferson University, City of Hope. Active years: 2015-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kendra Nicole Avery. Retrieved from https://idiyas.com/inventor/kendra-nicole-avery

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8 

% Patents Active = 87.5


 

Average Co-Inventor Count = 5.6

ph-index = 4

Forward Citations = 62(Granted Patents)


Company Filing History:


Years Active: 2015-2026

Loading Chart...
Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Kendra Nicole Avery: Innovator in Therapeutic Antibodies

Introduction

Kendra Nicole Avery is a prominent inventor based in Pasadena, CA. She has made significant contributions to the field of therapeutic antibodies, holding a total of 8 patents. Her innovative work focuses on developing advanced solutions to enhance the efficacy and safety of antibody therapies.

Latest Patents

Among her latest patents is the development of masked therapeutic antibodies designed to limit off-target effects. In one embodiment, a masked monoclonal antibody (mAb) is provided, which is encoded by a nucleic acid sequence or an amino acid sequence molecule comprising a signal sequence, a masking epitope sequence, a linker sequence that is cleavable by a protease specific to a target tissue. In another embodiment, a masked monoclonal antibody (mAb) is provided, which includes a therapeutic mAb and a mask, the mask comprising protein A and protein L attached by a protease cleavable linker. Additionally, she has patented meditopes and meditope-binding antibodies, which include antibodies and meditopes that bind to the antibodies, as well as complexes, compositions, and combinations containing the meditopes and antibodies. These innovations encompass methods of producing, using, testing, and screening the same, including therapeutic and diagnostic methods and uses.

Career Highlights

Kendra has worked with esteemed institutions such as City of Hope and Thomas Jefferson University. Her work at these organizations has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research in therapeutic applications.

Collaborations

Some of her notable coworkers include John C. Williams and Cindy Zer. Their collaborative efforts have further advanced the research and development of innovative therapeutic solutions.

Conclusion

Kendra Nicole Avery's contributions to the field of therapeutic antibodies exemplify her dedication to innovation and research. Her patents and collaborations highlight her role as a leading inventor in this critical area of medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…